Deucravacitinib is under clinical development by Bristol-Myers Squibb and currently in Phase II for Rosacea. According to GlobalData, Phase II drugs for Rosacea have a 38% phase transition success ...
Fostamatinib disodium is under clinical development by Rigel Pharmaceuticals and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Pneumonia.
Medically reviewed by Marisa Garshick, MD Laser hair removal is a safe and effective option for treating hidradenitis ...
Treatment involves avoiding the irritant and using creams or ointments to repair ... Shaving or waxing are common ways people ...